Gavin Grey: UK Correspondent on the study showing potential heart benefits of weight loss medication
Early Edition with Ryan Bridge · Newstalk ZB
Audio is streamed directly from the publisher (pdst.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
A UK study has found that obesity jabs could reduce health risks.
Researchers looked at semaglutide, otherwise known as Wegovy and Ozempic, and found that the weekly shots could reduce the risk of heart attacks and strokes.
It was found to benefit cardiovascular health even if the user didn’t lose much weight.
UK Correspondent Gavin Grey told Roman Travers that it’s too early to say that it’s definitely working and definitely a side effect, but the potential is fascinating.
LISTEN ABOVE
See omnystudio.com/listener for privacy information.